Increasing Investment in Research is Propelling the Growth of the Rabies Vaccine Market in the APAC Region!
- Vikas Kumar
- December 23, 2023
- HEALTHCARE, NEWS
- Rabies Vaccine Market Analysis, Rabies Vaccine Market Forecast, Rabies Vaccine Market Growth, Rabies Vaccine Market Outlook, Rabies Vaccine Market Share, Rabies Vaccine Market Size, Rabies Vaccine Market Trends
- 0 Comments
The Asia Pacific rabies vaccine market is one of the largest and fastest-growing markets globally. The region includes countries such as China, India, Japan, Australia, South Korea, and several Southeast Asian nations. The increasing awareness about rabies prevention, rising pet ownership, government initiatives for animal vaccination programs, and growing medical tourism are the important factor driving the growth rabies vaccine market in APAC. For instance, in March 2022, Government of India launched the National Rabies Control Programme (NRCP) for the prevention and control of Rabies.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=44167
Further, the Asia-Pacific Rabies vaccine Market is expected to grow at a strong CAGR of 5% during the forecast period (2022-2030). The increasing demand for rabies vaccine due to the rising healthcare expenditure, along with the increasing research & development efforts in the region.
APAC Rabies Vaccine Market Revenue (2020-2030)- USD Mn
Based on product type, the market is segmented into vero cell rabies vaccine, baby hamster kidney (BHK), chick embryo cell rabies vaccine, and others. As per our analysis, the vero cell rabies vaccine segment acquired a major share in 2021. Vero cell rabies vaccine is an inactivated rabies vaccine that is produced using Vero cells, which are a continuous line of monkey kidney cells. This type of vaccine has been widely used for several years for rabies immunization. It has been found to be safe and effective in preventing rabies in humans. The for effective rabies prevention, particularly in regions where rabies is prevalent. Rabies is a viral disease that affects the central nervous system and is almost always fatal once symptoms appear are the main reasons for the growth of the segment.
Based on the application, the market is segmented into pre-exposure prophylaxis and post-exposure prophylaxis. The pre-exposure prophylaxis segment is expected to grow with a higher CAGR in the rabies vaccine market during the forecast period. The increasing awareness about rabies and increasing pet population attributes to the fast growth of the segment during the forecast period.
Based on the distribution channel, the market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. As per our analysis, the hospital pharmacy segment acquired a major share in 2021. Hospital pharmacies play a crucial role in the rabies vaccine market by ensuring the availability, storage, and distribution of rabies vaccines to healthcare facilities and patients. Hospital pharmacies are responsible for procuring an adequate supply of rabies vaccines from vaccine manufacturers or authorized distributors. They monitor vaccine inventory levels, expiration dates, and ensure proper storage conditions to maintain vaccine efficacy.
For a detailed analysis of Global Rabies vaccine Market browse through – https://univdatos.com/report/rabies-vaccine-market/
Global Rabies Vaccine Market Segmentation
Market Insight, by Product Type
- Vero Cell Rabies Vaccine
- Baby Hamster Kidney (BHK)
- Chick Embryo Cell Rabies Vaccine
- Others
Market Insight, by Application
- Pre-Exposure Prophylaxis
- Post-Exposure Prophylaxis
Market Insight, by Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Market Insight, by Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- APAC
- China
- Japan
- India
- Rest of APAC
- Rest of the World
Top Company Profiles
• Serum Institute of India Pvt. Ltd.
• Novartis AG
• Cadila Pharmaceuticals
• Merck & Co., Inc.
• Sanofi
• Berna Biotech Pharma GmbH.
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Elanco
• Zoetis
